Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,180
datasets available to search
ShareScore release 0.9.0
Dataset results
2,180 results for “Recombination”
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
ClinicalTrials.gov study NCT00816660. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
ClinicalTrials.gov study NCT01087333. IPD Sharing: YES. Countries: 1. Publications: 4.
A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects
ClinicalTrials.gov study NCT00311519. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
ClinicalTrials.gov study NCT02464319. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as No
ClinicalTrials.gov study NCT03916185. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
ClinicalTrials.gov study NCT04239313. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors
ClinicalTrials.gov study NCT03704246. IPD Sharing: NO. Countries: 1. Publications: 2.
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Vo
ClinicalTrials.gov study NCT00427453. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
ClinicalTrials.gov study NCT01727076. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's Surgery
ClinicalTrials.gov study NCT02059694. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above
ClinicalTrials.gov study NCT05069129. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
ClinicalTrials.gov study NCT01356823. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines
ClinicalTrials.gov study NCT01203319. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A
ClinicalTrials.gov study NCT00157040. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00072969. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma
ClinicalTrials.gov study NCT00429312. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine
ClinicalTrials.gov study NCT05656508. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov study NCT00000725. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)
ClinicalTrials.gov study NCT04227665. IPD Sharing: NO. Countries: 1. Publications: 1.
Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis
ClinicalTrials.gov study NCT03835507. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.